Increased Circulating Erythrocyte-Derived Microparticles in Patients with Acute Coronary SyndromesHai-Xia Liao, Hui Zhu, Guo‐kai Shang et al.|Biomarkers in Medicine|2021Cited by 2
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor ImmunityXin Yu, Jin Wang|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 2